BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37953462)

  • 1. A Mammalian Conserved Circular RNA CircLARP1B Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism.
    Li J; Wang X; Shi L; Liu B; Sheng Z; Chang S; Cai X; Shan G
    Adv Sci (Weinh); 2024 Jan; 11(2):e2305902. PubMed ID: 37953462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N
    Lu J; Ru J; Chen Y; Ling Z; Liu H; Ding B; Jiang Y; Ma J; Zhang D; Ge J; Li Y; Sun F; Chen D; Zheng S; Wu J
    Clin Transl Med; 2023 Oct; 13(10):e1451. PubMed ID: 37877357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.
    Martínez-López N; Varela-Rey M; Fernández-Ramos D; Woodhoo A; Vázquez-Chantada M; Embade N; Espinosa-Hevia L; Bustamante FJ; Parada LA; Rodriguez MS; Lu SC; Mato JM; Martínez-Chantar ML
    Hepatology; 2010 Nov; 52(5):1621-31. PubMed ID: 20815019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks.
    Liu C; Huang R; Yu H; Gong Y; Wu P; Feng Q; Li X
    Phytomedicine; 2022 Aug; 103():154226. PubMed ID: 35689900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
    Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
    Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.
    Zubiete-Franco I; García-Rodríguez JL; Lopitz-Otsoa F; Serrano-Macia M; Simon J; Fernández-Tussy P; Barbier-Torres L; Fernández-Ramos D; Gutiérrez-de-Juan V; López de Davalillo S; Carlevaris O; Beguiristain Gómez A; Villa E; Calvisi D; Martín C; Berra E; Aspichueta P; Beraza N; Varela-Rey M; Ávila M; Rodríguez MS; Mato JM; Díaz-Moreno I; Díaz-Quintana A; Delgado TC; Martínez-Chantar ML
    EBioMedicine; 2019 Feb; 40():406-421. PubMed ID: 30594553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.
    Li X; Ding J; Wang X; Cheng Z; Zhu Q
    Oncogene; 2020 Jan; 39(4):891-904. PubMed ID: 31570791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of circular RNAs in the development of hepatocellular carcinoma.
    Hussen BM; Honarmand Tamizkar K; Hidayat HJ; Taheri M; Ghafouri-Fard S
    Pathol Res Pract; 2021 Jul; 223():153495. PubMed ID: 34051512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma.
    Wang L; Li H; Zhen Z; Ma X; Yu W; Zeng H; Li L
    Gene; 2019 Mar; 690():129-136. PubMed ID: 30597237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
    Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
    Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 13. LKB1 signaling is activated in CTNNB1-mutated HCC and positively regulates β-catenin-dependent CTNNB1-mutated HCC.
    Charawi S; Just PA; Savall M; Abitbol S; Traore M; Metzger N; Ravinger R; Cavard C; Terris B; Perret C
    J Pathol; 2019 Apr; 247(4):435-443. PubMed ID: 30566242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
    Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
    Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The circular RNA circMAST1 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-1299 and regulating CTNND1 expression.
    Yu X; Sheng P; Sun J; Zhao X; Zhang J; Li Y; Zhang Y; Zhang W; Wang J; Liu K; Zhu D; Jiang H
    Cell Death Dis; 2020 May; 11(5):340. PubMed ID: 32393764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma.
    Yang J; Li Y; Yu Z; Zhou Y; Tu J; Lou J; Wang Y
    Mol Med Rep; 2020 Jun; 21(6):2395-2404. PubMed ID: 32323783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naa20, the catalytic subunit of NatB complex, contributes to hepatocellular carcinoma by regulating the LKB1-AMPK-mTOR axis.
    Jung TY; Ryu JE; Jang MM; Lee SY; Jin GR; Kim CW; Lee CY; Kim H; Kim E; Park S; Lee S; Lee C; Kim W; Kim T; Lee SY; Ju BG; Kim HS
    Exp Mol Med; 2020 Nov; 52(11):1831-1844. PubMed ID: 33219302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
    Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
    J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cullin-associated and neddylation-dissociated 1 regulate reprogramming of lipid metabolism through SKP1-Cullin-1-F-box
    Zhang H; Xia P; Yang Z; Liu J; Zhu Y; Huang Z; Zhang Z; Yuan Y
    Clin Transl Med; 2023 Oct; 13(10):e1443. PubMed ID: 37837399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.